Laser plus Geniwa gel for recurring genital warts
Part of Infections, Skin clinical trials.
This trial tests whether adding a special gel (Geniwa gel) to standard laser treatment helps prevent genital warts from coming back. It may be an option for people who have already tried laser treatment but their warts returned.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Aged 18 years or older
- Have genital or anal warts that are clearly visible
- Have had at least 2 laser treatments in the past, and your warts came back after that
- Have at least 4 warts, or the wart area is at least 0.5 square centimeters
- Do not have an active sexually transmitted infection like gonorrhea, syphilis, or genital herpes
- Not be pregnant or allergic to any ingredient in the gel
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a vaginal gel that may help restore the health of the cervix in women with HPV. It aims to see if the gel can improve cervical tissue and potentially help clear the infection.
This study tests whether an HPV vaccine can help shrink or clear cutaneous (skin) warts that have not responded to prior treatments. Participants get the study vaccine or a placebo to compare results and safety.
This study tests three treatments for warts on the skin (not on the genitals): platelet-rich plasma (a substance made from your own blood that may help healing), metformin (a medicine usually for diabetes), and cryotherapy (freezing the wart). The goal is to see which treatment works best and is safest.
This trial tests whether applying heat combined with a common disinfectant (hydrogen peroxide) can safely and effectively remove viral skin warts. It may be an option if you have common, plantar, or genital warts and are between 16 and 65 years old.
This study compares a gel applied to the skin versus a freezing treatment for plantar warts that keep coming back. It will help find which treatment works better for people with recurring warts on the feet.
This trial studies 2LPAPI® to see if it helps the body clear high-risk HPV infections in the cervix. It may be an option if you have a current HPV infection with mild/early abnormal cervical findings and can complete follow-up for about a year.
Hear when a new HPV (Human Papillomavirus)-Associated trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.